| scholarly article | Q13442814 |
| P50 | author | Jeffrey L. Cummings | Q6175920 |
| Leon J. Thal | Q56839882 | ||
| P2093 | author name string | Rochelle E Tractenberg | |
| Marian B Patterson | |||
| Myron F Weiner | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| The Clinical Dementia Rating (CDR): current version and scoring rules | Q29616280 | ||
| Behavior Rating Scale for Dementia: development of test scales and presentation of data for 555 individuals with Alzheimer's disease | Q30586033 | ||
| Executive functions and their disorders | Q30786154 | ||
| Cholinesterase inhibitors: A new class of psychotropic compounds | Q33807472 | ||
| Executive cognitive impairment: a novel perspective on dementia | Q34074488 | ||
| Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update | Q34143605 | ||
| Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers. | Q34390162 | ||
| A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study | Q34433704 | ||
| An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. | Q34433716 | ||
| Adult clinical neuropsychology: lessons from studies of the frontal lobes | Q34467591 | ||
| Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. | Q34994002 | ||
| Neuropsychiatric features of frontotemporal dementia: evaluation of consensus criteria and review | Q34994009 | ||
| Qualifying change: a method for defining clinically meaningful outcomes of change score computation | Q35200967 | ||
| Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's disease | Q35211956 | ||
| Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited | Q41152318 | ||
| Dementias that present with and without posterior cortical features: an important clinical distinction | Q41684963 | ||
| Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients. | Q42631476 | ||
| Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study | Q42633058 | ||
| Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes | Q46079295 | ||
| Clinicometabolic dissociation of cognitive functions and social behavior in frontal lobe lesions | Q48425131 | ||
| Executive dysfunction in geriatric depression | Q48564598 | ||
| Behavioral Syndromes in Alzheimer's Disease | Q48605464 | ||
| Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale. | Q48833811 | ||
| Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease | Q48944777 | ||
| A new clinical scale for the staging of dementia. | Q52220854 | ||
| The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease | Q53201306 | ||
| A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study. | Q53218523 | ||
| Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms. | Q53220164 | ||
| Longitudinal course of behavioral problems during Alzheimer's disease: linear versus curvilinear patterns of decline | Q73793088 | ||
| P433 | issue | 1 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 51-60 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Journal of Neuropsychiatry and Clinical Neurosciences | Q15753636 |
| P1476 | title | Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach | |
| P478 | volume | 17 |
| Q33646545 | Agreement in cognitive and clinical assessments in Alzheimer's disease |
| Q64120895 | Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia |
| Q40205534 | Association of neuropsychiatric syndromes with global clinical deterioration in Alzheimer's disease patients |
| Q37211097 | Behavioral symptoms related to cognitive impairment |
| Q36348920 | Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition |
| Q36047779 | Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study |
| Q45836746 | Dimensionality of burden in Alzheimer caregivers: confirmatory factor analysis and correlates of the Zarit Burden interview |
| Q37338008 | For whom and for what the definition of severe dementia is useful: an EDCON consensus. |
| Q35053648 | Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach |
| Q37685048 | Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease |
| Q46404384 | Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study |
| Q44279931 | Seeing with new eyes: finding a path to early intervention trials in Alzheimer's disease |
| Q37693554 | Social cognition in Alzheimer's disease: a separate construct contributing to dependence |
| Q49679713 | Subcortical Vascular Cognitive Impairment staged through cdr's functional subsum (cdr-func): Preliminary results from an outpatient sample. |
| Q37068194 | The ADAS-Cog revisited: novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials |
| Q38588411 | The Electrophysiological Phenomenon of Alzheimer's Disease: A Psychopathology Theory |
Search more.